Intuitive Surgical | ISRG - Cash And Equivalent


Intuitive Surgical reported $7.98B in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Abbott USD 6.8B 1.72B Mar/2026
Agilent USD 1.81B 49M Mar/2026
Avanos Medical USD 65.6M 24.2M Mar/2026
Baxter International USD 2.02B 51M Mar/2026
Becton, Dickinson and Co. USD 813M 73M Mar/2026
Boston Scientific USD 1.45B 512M Mar/2026
Charles River Laboratories USD 191.83M 21.94M Mar/2026
CONMED USD 40.82M 1.89M Dec/2025
Danaher USD 5.7B 1.09B Mar/2026
Dentsply International USD 190M 136M Mar/2026
Dexcom USD 1.12B 200.5M Mar/2026
Edwards Lifesciences USD 2.4B 538M Mar/2026
Globus Medical USD 560.95M 34.79M Mar/2026
Illumina USD 1.42B 368M Dec/2025
Insulet USD 480.4M 235.7M Mar/2026
Integra LifeSciences USD 236.81M 1.76M Mar/2026
Intuitive Surgical USD 7.98B 1.05B Mar/2026
J&J USD 21.69B 1.98B Mar/2026
Medtronic USD 1.15B 135M Dec/2025
Mettler Toledo International USD 66.89M 2.18M Dec/2025
Olympus JPY 147.24B 93.98B Sep/2025
Revvity USD 860.32M 59.54M Mar/2026
Steris USD 423.7M 104.5M Dec/2025
Stryker USD 2.88B 1.13B Mar/2026
Teleflex USD 309.41M 69.15M Mar/2026
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Waters USD 462M 125.83M Mar/2026
Zimmer Biomet Holdings USD 424.2M 167.7M Mar/2026